| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Picasso Did Not Work By The Hour! |
|
Main Subject - Picasso Did Not Work By The Hour!
I write some of my best articles, books, and coaching and consulting proposals in the wee hours of the morning, long before d According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product awn. Officially, this is not during a 9-5, business day, is it? What if I wanted to sell these precious hours to an employe ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in , with the assertion that this is when I perform best? Do you think I could line-up a job, say with a publisher, to come into lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. headquarters between 1-5 in the morning? Probably, not, right? After all, who is going to supervise me? Will the lights and here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ir conditioning even function at that time? No, most employers implicitly say to creative people, create when we want you to d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro when we’re here, or else. Isn’t this just a little unrealistic, if not counterproductive? But it’s just one way in which th ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc working world structures work, based on artificial criteria. Let’s delve even deeper into the mysteries of the way work is easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi defined, offered, and managed. For instance, I don’t know anybody who is paid by the idea, yet ideas are supremely important nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically right? Similarly, good judgment is crucial to the success of an enterprise, but do you know people who are paid by the judg and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ent? I was called by a former client who was asked me whether a certain electronic device could be sold over the phone, prof ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi tably. I replied that I needed to meet with him for a day to become familiar with the device, the pricing, and so forth. “Na ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ,” he rebutted, “You’re a pro; just give me your gut reaction!” He didn’t want to pay me for a day; in fact, he didn’t want dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod o pay at all. By the way, my gut said “Don’t do it; it can’t be sold over the phone at a profit.” But I bit my tongue, and cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e went off and lost millions trying to sell it that way. I couldn’t get away with billing say, $3,500 for my reply, though i tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen t was clearly worth that, because business people aren’t used to paying by the opinion, by the judgment. In fact, if they th t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel nk you’re so sharp that you can easily disgorge the answer, they think that you should do so, as a favor. Why? Because it di ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust n’t take substantial clock time to generate. I saw a film about the famous artist, Pablo Picasso. He worked so fast it was a y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products azing; finishing drawings and cool paintings in mere minutes. Should he have charged by the minute or by the hour for his ar . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ? Could he have paid the rent that way? Here’s my point: we need to encourage people to charge and to be paid differently fo elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip their contributions, in recognition of the value they bestow, not based on the time or place in which the work was performed tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Controlling Beverage Costs For Your Restaurant How To Prepare For A Psychometric Test
|